Houston A - Search Results

1

Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway.

O'Mahony C, Clooney A, Clarke SF, Aguilera M, Gavin A, Simnica D, Ahern M, Fanning A, Stanley M, Rubio RC, Patterson E, Marques T, Wall R, Houston A, Mahmoud A, Bennett MW, Stanton C, Claesson MJ, Cotter PD, Shanahan F, Joyce SA, Melgar S. O'Mahony C, et al. Among authors: houston a. Int J Mol Sci. 2023 Jan 18;24(3):1864. doi: 10.3390/ijms24031864. Int J Mol Sci. 2023. PMID: 36768196 Free PMC article.

2

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F. O'Connell J, et al. Among authors: houston a. Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. doi: 10.1111/j.1749-6632.2000.tb06708.x. Ann N Y Acad Sci. 2000. PMID: 10911913 Review.

3

Immune privilege or inflammation? Insights into the Fas ligand enigma.

O'Connell J, Houston A, Bennett MW, O'Sullivan GC, Shanahan F. O'Connell J, et al. Among authors: houston a. Nat Med. 2001 Mar;7(3):271-4. doi: 10.1038/85395. Nat Med. 2001. PMID: 11231613

4

Fas ligand upregulation is an early event in colonic carcinogenesis.

Bennett MW, O'Connell J, Houston A, Kelly J, O'Sullivan GC, Collins JK, Shanahan F. Bennett MW, et al. Among authors: houston a. J Clin Pathol. 2001 Aug;54(8):598-604. doi: 10.1136/jcp.54.8.598. J Clin Pathol. 2001. PMID: 11477113 Free PMC article.

5

Rapid development of a quantitative-competitive (qc) RT-PCR assay using a composite primer approach.

O'Connell J, Houston A, Kelly R, O'Brien D, Ryan A, Bennett MW, Nally K. O'Connell J, et al. Among authors: houston a. Methods Mol Biol. 2002;193:93-102. doi: 10.1385/1-59259-283-X:093. Methods Mol Biol. 2002. PMID: 12325528 No abstract available.

6

Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.

Houston A, Waldron-Lynch FD, Bennett MW, Roche D, O'Sullivan GC, Shanahan F, O'Connell J. Houston A, et al. Int J Cancer. 2003 Nov 1;107(2):209-14. doi: 10.1002/ijc.11392. Int J Cancer. 2003. PMID: 12949796 Free article.

7

Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.

Houston A, Bennett MW, O'Sullivan GC, Shanahan F, O'Connell J. Houston A, et al. Br J Cancer. 2003 Oct 6;89(7):1345-51. doi: 10.1038/sj.bjc.6601240. Br J Cancer. 2003. PMID: 14520470 Free PMC article.

8

Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.

Ryan AE, Shanahan F, O'Connell J, Houston AM. Ryan AE, et al. Cancer Res. 2005 Nov 1;65(21):9817-23. doi: 10.1158/0008-5472.CAN-05-1462. Cancer Res. 2005. PMID: 16267003

9

Fas ligand promotes tumor immune evasion of colon cancer in vivo.

Ryan AE, Shanahan F, O'Connell J, Houston AM. Ryan AE, et al. Cell Cycle. 2006 Feb;5(3):246-9. doi: 10.4161/cc.5.3.2413. Epub 2006 Feb 14. Cell Cycle. 2006. PMID: 16418579

10

Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data.

Ryan AE, Lane S, Shanahan F, O'Connell J, Houston AM. Ryan AE, et al. J Carcinog. 2006 Feb 2;5:5. doi: 10.1186/1477-3163-5-5. J Carcinog. 2006. PMID: 16457714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

545 results

Search Page